Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Multicenter Trial With IC41, a Therapeutic HCV Vaccine in Patients With Chronic HCV

NCT00601770 is registered in ClinicalTrials.gov with Valneva Austria GmbH as lead sponsor.

NCT NCT00601770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00601770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Multicenter Trial With IC41, a Therapeutic HCV Vaccine in Patients With Chronic HCV
Lead sponsor
Valneva Austria GmbH
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
July 31, 2008
Enrollment
71 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c